
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
Bayer Corp. has received FDA approval to market ciprofloxacin extended-releasetablets (Cipro XR), 500 mg, for the treatment of uncomplicated UTI. Thequinolone antibiotic is formulated for use once a day over a 3-day period.





